ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,232, issued on June 24, was assigned to Terns Inc. (Foster City, Calif.).
"THRBeta receptor agonist compound and preparation method and use thereof" was invented by Shanghai Yu (Kun Shan, China) and Ben Li (Kun Shan, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRAlpha selectivity while maintaining good THRBeta agonistic activity, thereby improving properties of the finished drug."
The patent was filed on May 10, 2023, under Application No. 18/315,291.
*For further information, inclu...